Home
Conditions
Digestive System Neoplasms

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,337 public trials 3,266 recruiting studies

Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors

NCT02009631

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +38 more
Locations: Site Reference ID/Investigator# 116015 Scottsdale, Arizona, United States

Site Reference ID/Investigator# 116016 San Antonio, Texas, United States

Site Reference ID/Investigator# 117320 Groningn, Netherlands

Site Reference ID/Investigator# 117336 Maastricht, Netherlands

View Trial Details

Completed

A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy

NCT01297998

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Kobe University Graduate School of Medicine Kobe, Japan

View Trial Details

Completed

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

NCT00387387

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: GSK Investigational Site Hyderabad, Andhra Pradesh, India

GSK Investigational Site Pārel, India

GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom

GSK Investigational Site Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

NCT00370513

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: GSK Investigational Site San Francisco, California, United States

GSK Investigational Site Hong Kong

GSK Investigational Site Taipei, Taiwan

View Trial Details

Completed

Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors

NCT01324258

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Bronchial Neoplasms, +16 more
Locations: GSK Investigational Site Osaka, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

NCT00666978

Conditions: Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +78 more
Locations: Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City, Kansas, United States

Swope Health Central Kansas City, Missouri, United States

View Trial Details

Completed

Caphosol in Oral Mucositis Due to Targeted Therapy

NCT01265810

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +29 more
Locations: The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands

Leiden University Medical Centre (LUMC) Leiden, Netherlands

View Trial Details

Completed

Endoscopic Treatment of Inoperable Colorectal Cancer With the EndoVe System

NCT01172860

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Mercy University Hospital Cork, Ireland

View Trial Details

Completed

A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

NCT00955773

Conditions: Cancer, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations: GSK Investigational Site Nashville, Tennessee, United States

GSK Investigational Site San Antonio, Texas, United States

GSK Investigational Site Paris, France

View Trial Details

Completed

Biospecimens for Identification of Diseases of the Pancreas.

NCT01392027

Conditions: Chronic Disease, Chronic Pancreatitis, Cysts, +23 more
Locations: Univerisity of Michigan Ann Arbor, Michigan, United States

View Trial Details

Digestive System Neoplasms

Digestive System Neoplasms trial results

Related conditions